Literature DB >> 11147803

Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation.

H Koyama1, K E Bornfeldt, S Fukumoto, Y Nishizawa.   

Abstract

Cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) are second messengers involved in the intracellular signal transduction of a wide variety of extracellular stimuli. These signals regulate many biological processes including cell proliferation, differentiation, migration, and apoptosis. Recently, significant progress has been achieved in the molecular basis underlying cyclic nucleotide regulation of cell proliferation. This review summarizes our knowledge of the signaling pathways regulated by cyclic nucleotides in arterial smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11147803     DOI: 10.1002/1097-4652(200101)186:1<1::AID-JCP1012>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.

Authors:  Najma Begum; Steven Hockman; Vincent C Manganiello
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1.

Authors:  Fernanda R Giachini; Victor V Lima; Fernando S Carneiro; Rita C Tostes; R Clinton Webb
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

3.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

Authors:  G M Pitari; M D Di Guglielmo; J Park; S Schulz; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: implications in cardiovascular diseases and infertility.

Authors:  Najma Begum; Weixing Shen; Vincent Manganiello
Journal:  Curr Opin Pharmacol       Date:  2011-11-01       Impact factor: 5.547

5.  Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells.

Authors:  Chrystelle V Garat; Dana Fankell; Paul F Erickson; Jane E-B Reusch; Natalie N Bauer; Ivan F McMurtry; Dwight J Klemm
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

6.  Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle.

Authors:  Alexander Ivanov; Volodymyr Gerzanich; Svetlana Ivanova; Ryan Denhaese; Orest Tsymbalyuk; J Marc Simard
Journal:  J Physiol       Date:  2005-11-10       Impact factor: 5.182

7.  Rutaecarpine Inhibits Intimal Hyperplasia in A Balloon-Injured Rat Artery Model.

Authors:  Yang Xu; Xiu-Ping Chen; Feng Zhang; Hua-Hua Hou; Jing-Yi Zhang; Shu-Xian Lin; An-Sheng Sun
Journal:  Chin J Integr Med       Date:  2017-09-01       Impact factor: 1.978

8.  Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors.

Authors:  A H Eid; M A Chotani; S Mitra; T J Miller; N A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

9.  Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.

Authors:  David J Nagel; Toru Aizawa; Kye-Im Jeon; Weimin Liu; Amy Mohan; Heng Wei; Joseph M Miano; Vincent A Florio; Pingjin Gao; Vyacheslav A Korshunov; Bradford C Berk; Chen Yan
Journal:  Circ Res       Date:  2006-03-02       Impact factor: 17.367

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.